MD MelanClear for Pigmentation: How Does It Work?
By Dr Matete Mathobela
Reviewed by Dr Matete Mathobela – Specialist Dermatologist practising in Century City, Cape Town, Cape Gate Mediclinic and Life West Coast Private Hospital. Founder of MD Cosmeceuticals by Matete Derma and MD DermOutlet.
Read more about Dr Matete Mathobela →
Medical Disclaimer
This article is for general educational purposes and does not replace individual medical advice. Pigmentation has many causes, and treatment should be tailored to the underlying diagnosis and individual skin needs.
What Is MD MelanClear?
MelanClear for pigmentation is a targeted multi-ingredient serum from MD Cosmeceuticals by Matete Derma. Rather than relying on a single brightening ingredient, it combines ingredients that work at different stages of the pigmentation pathway, including pigment signalling, melanin production and melanosome transfer.
Key ingredients include tranexamic acid, undecylenoyl phenylalanine, butylresorcinol, alpha-arbutin, kojic acid, niacinamide, sodium ascorbyl phosphate and tetrapeptide-30.
In simple terms, the formulation aims to turn down signals that stimulate pigmentation, slow the production of new melanin and reduce the transfer of pigment into surrounding skin cells.
Shop MD MelanClear →
How Does MelanClear for Pigmentation Work?
Pigmentation is not controlled by one process.
Signals within the skin can activate melanocytes. These cells produce melanin, which is packaged into melanosomes and transferred into surrounding keratinocytes, where pigmentation becomes visible.
MelanClear targets several of these steps.
How MelanClear Targets Pigmentation at Different Stages
| Key ingredient | Where it works | How it helps — in simple terms |
|---|---|---|
| Tranexamic acid | Pigmentation signalling | Helps turn down some of the signals that can stimulate melanocytes, reducing the drive to produce excess pigment. |
| Undecylenoyl phenylalanine | α-MSH / melanocortin signalling | Helps interrupt one of the messages that tells melanocytes to increase pigment production. |
| Butylresorcinol | Tyrosinase & pigment-forming enzymes | Helps inhibit tyrosinase and other enzymes involved in melanin production. |
| Alpha-arbutin | Tyrosinase pathway | Provides additional support by slowing the enzyme involved in producing excess melanin. |
| Kojic acid | Tyrosinase pathway | Helps reduce tyrosinase activity by interfering with the copper the enzyme needs to work. |
| Niacinamide | Pigment transfer | Helps reduce the transfer of pigment from melanocytes into surrounding skin cells, where it becomes visible. |
| Sodium ascorbyl phosphate | Antioxidant support | A vitamin C derivative that provides antioxidant and additional brightening support. |
| Tetrapeptide-30 | Uneven-tone support | Provides additional support for improving the appearance of uneven pigmentation. |
In simple terms: MelanClear does not rely on one brightening ingredient. Its ingredients target pigmentation at several points — from the signals that stimulate melanocytes, to melanin production itself, pigment transfer and antioxidant support.
Why Does MelanClear Contain Several Tyrosinase Inhibitors?
Butylresorcinol, alpha-arbutin and kojic acid all target the melanin-production stage, but they are not identical.
- Butylresorcinol inhibits of tyrosinase and helps suppress melanin production.
- Alpha-arbutin also inhibits tyrosinase, providing additional pigment-suppressing activity.
- Kojic acid inhibits tyrosinase partly by interfering with the copper the enzyme requires to function.
It is therefore better to think of them as complementary ingredients acting on the pigment-production machinery, rather than three completely separate pigmentation pathways.
What Can MD MelanClear Be Used For?
MD MelanClear may be incorporated into routines for:
- Post-inflammatory hyperpigmentation (PIH) following acne or inflammation
- Melasma, as part of a broader treatment and photoprotection plan
- Uneven skin tone
- Dark marks following inflammatory skin lesions
The underlying diagnosis still matters. Melasma, acne-related PIH and other pigmentary disorders do not necessarily require the same treatment approach.
Persistent or unusual pigmentation should be properly assessed rather than simply treated with increasingly strong brightening products.
How Do I Use MD MelanClear?
MD MelanClear can generally be used once daily, depending on your skin, the rest of your routine and tolerance.
A simple evening routine is:
MD Creamy Cleanser → MD MelanClear → MD Rich Moisturiser if needed
For patients who require additional treatment, MelanClear can also be incorporated into a more targeted pigmentation routine.
What Can I Use With MD MelanClear?
MD Brightening Cream or MD Niacinamide Peptides Serum
Both can complement MelanClear, but you don’t necessarily need both.
MD Brightening Cream is a good morning option when pigmentation is the main treatment goal.
The MD Cosmeceuticals Niacinamide Peptides Serum is useful when you want additional pigment, antioxidant and early-ageing support.
Choose according to what your skin needs rather than adding both simply because they are available.
Vitamin C
Vitamin C can also complement MelanClear by providing antioxidant and brightening support.
A simple approach is to use a Vitamin C serum in the morning and MelanClear in the evening.
You do not need Vitamin C, Brightening Cream and Niacinamide Peptides Serum all in the same morning routine.
Can I Use MD MelanClear With the MD Retinoid Cream?
Yes. MD MelanClear and MD Retinoid Cream can be used in the same evening routine if your skin tolerates them well.
The MD Retinoid Cream contains hydroxypinacolone retinoate (HPR), bakuchiol and niacinamide. It can be particularly useful when pigmentation occurs alongside acne, uneven texture or early signs of ageing.
A treatment-focused evening routine could be:
MD Creamy Cleanser → MD MelanClear → MD Retinoid Cream → MD Rich Moisturiser if needed
The retinoid is optional. It does not need to be added simply because you are treating pigmentation.
If you are new to retinoids or have sensitive skin, introduce the combination gradually and reduce frequency if irritation develops.
What About Exfoliating Acids?
More exfoliation does not necessarily mean faster pigment clearance.
Because MelanClear already contains several active pigmentation ingredients, exfoliating acids should be added for a specific reason, rather than automatically being layered into the routine.
Excessive irritation can worsen post-inflammatory pigmentation, particularly in pigmentation-prone skin.
A Practical MD MelanClear Pigmentation Routine
| Morning | Evening |
|---|---|
| MD Creamy Cleanser | MD Creamy Cleanser |
| MD Brightening Cream OR MD Niacinamide Peptides Serum | MD MelanClear |
| MD Tinted Sunscreen | MD Retinoid Cream if required |
| — | MD Rich Moisturiser if needed |
Choose your morning treatment according to your goal: MD Brightening Cream provides more targeted pigmentation support, while MD Niacinamide Peptides Serum provides pigment support together with antioxidant and early-ageing benefits.
The retinoid is optional: Add MD Retinoid Cream when you also want to address acne, uneven texture or early ageing.
A Vitamin C serum can also be used as an alternative morning antioxidant option.
Sunscreen Is Part of Pigmentation Treatment
No pigmentation serum can compensate for inadequate photoprotection.
Daily broad-spectrum sunscreen is fundamental when treating pigmentation. For pigmentation-prone skin, particularly melasma, a tinted sunscreen containing iron oxides can provide additional protection against visible light.
My Dermatologist’s Perspective
What I like about MD MelanClear is that the formulation approaches pigmentation at more than one point in the pathway. It combines ingredients that influence pigment signalling, melanin production and pigment transfer rather than relying on a single brightening ingredient.
In practice, however, treating pigmentation does not mean using as many active ingredients as possible. I prefer to build a routine around the diagnosis, a targeted pigment treatment and consistent photoprotection, then add other products only where they provide a clear additional benefit.
For persistent melasma, post-inflammatory hyperpigmentation or other pigmentary disorders, skincare may also need to form part of a broader dermatologist-directed treatment plan.
— Dr Matete Mathobela, Specialist Dermatologist and Founder of MD Cosmeceuticals by Matete Derma
Frequently Asked Questions
Is MelanClear for pigmentation only for melasma?
No. MelanClear for pigmentation may also be incorporated into routines for post-inflammatory hyperpigmentation, uneven skin tone and dark marks following acne or inflammation.
Can I use MelanClear every day?
It can generally be used once daily if well tolerated. Sensitive skin or a routine containing several active treatments may require a more gradual introduction.
Can I use MelanClear with Vitamin C?
Yes. A simple option is to use Vitamin C in the morning and MD MelanClear in the evening.
Can I use MelanClear with niacinamide?
Yes. MelanClear itself already contains niacinamide. An additional MD Niacinamide Peptides Serum is therefore optional, rather than essential.
Can I use MelanClear with the MD Retinoid Cream?
Yes, if tolerated. They can be used together in the evening, particularly when you want to address pigmentation alongside acne, uneven texture or early ageing. Introduce the combination gradually if your skin is sensitive or you are new to retinoids.
How long does MD MelanClear take to work?
Pigmentation improvement is generally gradual rather than immediate. Results depend on the type and depth of pigmentation, consistency of treatment and photoprotection.
Suggested Reading
- MD Cosmeceuticals: A Dermatologist Skincare Routine That Actually Works
- Hyperpigmentation: The Complete Dermatologist’s Guide
- How to Layer Skincare Products: A Dermatologist’s Simple Guide
Build Your Pigmentation Routine
Shop MD MelanClear →
Explore the MD Cosmeceuticals range →
Book an appointment with Dr Matete Mathobela →
References
- Hakozaki T, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. British Journal of Dermatology. 2002.
Read the niacinamide study on PubMed - Kim DS, et al. Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis. Biological & Pharmaceutical Bulletin. 2005.
Read the butylresorcinol study on PubMed - Kim SJ, et al. Efficacy and possible mechanisms of topical tranexamic acid in melasma. Clinical and Experimental Dermatology. 2016.
Read the tranexamic acid study on PubMed - AlJabr A, et al. Tranexamic Acid for Hyperpigmentation Disorders: A Literature Review on Efficacy and Safety in Melasma and PIH. Journal of Cosmetic Dermatology. 2026.
Read the 2026 review on PubMed - Castanedo-Cazares JP, et al. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. Photodermatology, Photoimmunology & Photomedicine.
Read the visible-light and iron-oxide study on PubMed
Like & Share